A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2013-01, Vol.31 (1), p.87-89
Hauptverfasser:	Allen, Rachel, Brainsky, Andres, Grotzinger, Kelly, Roccia, Tito
Format:	Artikel
Sprache:	eng
Schlagworte:	Benzoates - therapeutic use Correspondence Health Administration Health Economics Health technology assessment Humans Hydrazines - therapeutic use Medicine Medicine & Public Health Pharmacoeconomics and Health Outcomes Public Health Purpura, Thrombocytopenic, Idiopathic - drug therapy Pyrazoles - therapeutic use Quality of Life Research Technology Assessment, Biomedical - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!